A carregar...

Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma

INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Mian, Hira, Fiala, Mark, Wildes, Tanya M
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/
https://ncbi.nlm.nih.gov/pubmed/31843543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!